Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia
Not Applicable
Recruiting
- Conditions
- Alzheimer's DiseaseNeurodegenerative DiseasesDementiaCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersBrain DiseasesMental Disorder
- First Posted Date
- 2023-10-18
- Last Posted Date
- 2025-10-03
- Lead Sponsor
- Advanced Technology & Communications
- Target Recruit Count
- 158
- Registration Number
- NCT06088121
- Locations
- 🇰🇷
Catholic university of Korea Incheon St. Mary's Hospital, Incheon, Bupyeong 6(yuk)-dong, Bupyeong-gu, South Korea
🇰🇷Yeungnam University Medical Center, Daegu, Hyeonchung-ro, Nam-gu, South Korea
🇰🇷National Health Insurance Service Ilsan Hospital, Gyeonggi-do, Ilsan-ro, Ilsandong-gu, Goyang-si, South Korea
News
No news found